Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Benedict16thon Jun 22, 2020 11:34am
57 Views
Post# 31176670

RE:RE:RE:RE:RE:Dinosaur and Adaptations

RE:RE:RE:RE:RE:Dinosaur and Adaptations Guest/readers my last blast: If I did my constructive bit to place pressure and GUD MNGT to change it is becasue I beleive to be correct.  You can do your bit too. Placing constructive pressure on MNGT  is your shareholder right. Will it work? I hope so but do not hold your breath. Good luck on the upcoming AGM report.  I may be be back with greater criticism and strategic pressure the spring of 2021 if share prices do not get better and if I continue to be a shareholder of GUD. It depends on what they say or do not say Thursady and Friday. I always look for greener investemnt pastures and disruptive new industries. to inbest in.  I do own  shares of companies that  I have wrote about and many others and I have done a hell of a lot better than owing GUD for six Years. “the worst performer out of 30/35 holdings so far” As most investors I do not place all “the eggs in one basket as they say”. If I have pi ssed anyone well ..it is ….investment life get over it.  I do not take none of this personal including against GUD MNGT. Ciao 
Bullboard Posts